Literature DB >> 31285529

Report on three additional patients and genotype-phenotype correlation in SLC25A22-related disorders group.

Camille Lemattre1, Marion Imbert-Bouteille1, Vincent Gatinois1, Paule Benit2, Elodie Sanchez1,3, Thomas Guignard1, Frédéric Tran Mau-Them1,4, Emmanuelle Haquet1, François Rivier5, Emilie Carme5, Agathe Roubertie5, Anne Boland6, Doris Lechner6, Vincent Meyer6, Julien Thevenon7, Yannis Duffourd4, Jean-Baptiste Rivière4, Jean-François Deleuze6, Constance Wells1, Florence Molinari8, Pierre Rustin2, Patricia Blanchet1, David Geneviève9,10.   

Abstract

Early infantile epileptic encephalopathy (EIEE) is a heterogeneous group of severe forms of age-related developmental and epileptic encephalopathies with onset during the first weeks or months of life. The interictal electroencephalogram (EEG) shows a "suppression burst" (SB) pattern. The prognosis is usually poor and most children die within the first two years or survive with very severe intellectual disabilities. EIEE type 3 is caused by variants affecting function, in SLC25A22, which is also responsible for epilepsy of infancy with migrating focal seizures (EIMFS). We report a family with a less severe phenotype of EIEE type 3. We performed exome sequencing and identified two unreported variants in SLC25A22 in the compound heterozygous state: NM_024698.4: c.[813_814delTG];[818 G>A] (p.[Ala272Glnfs*144];[Arg273Lys]). Functional studies in cultured skin fibroblasts from a patient showed that glutamate oxidation was strongly defective, based on a literature review. We clustered the 18 published patients (including those from this family) into three groups according to the severity of the SLC25A22-related disorders. In an attempt to identify genotype-phenotype correlations, we compared the variants according to the location depending on the protein domains. We observed that patients with two variants located in helical transmembrane domains presented a severe phenotype, whereas patients with at least one variant outside helical transmembrane domains presented a milder phenotype. These data are suggestive of a continuum of disorders related to SLC25A22 that could be called SLC25A22-related disorders. This might be a first clue to enable geneticists to outline a prognosis based on genetic molecular data regarding the SLC25A22 gene.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31285529      PMCID: PMC6871179          DOI: 10.1038/s41431-019-0433-2

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  20 in total

1.  Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy.

Authors:  Florence Molinari; Annick Raas-Rothschild; Marlene Rio; Giuseppe Fiermonte; Ferechte Encha-Razavi; Luigi Palmieri; Ferdinando Palmieri; Ziva Ben-Neriah; Noman Kadhom; Michel Vekemans; Tania Attie-Bitach; Arnold Munnich; Pierre Rustin; Laurence Colleaux
Journal:  Am J Hum Genet       Date:  2004-12-08       Impact factor: 11.025

2.  ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology.

Authors:  Ingrid E Scheffer; Samuel Berkovic; Giuseppe Capovilla; Mary B Connolly; Jacqueline French; Laura Guilhoto; Edouard Hirsch; Satish Jain; Gary W Mathern; Solomon L Moshé; Douglas R Nordli; Emilio Perucca; Torbjörn Tomson; Samuel Wiebe; Yue-Hua Zhang; Sameer M Zuberi
Journal:  Epilepsia       Date:  2017-03-08       Impact factor: 5.864

3.  Contribution of glutamate dehydrogenase to mitochondrial glutamate metabolism studied by (13)C and (31)P nuclear magnetic resonance.

Authors:  S Aubert; R Bligny; R Douce; E Gout; R G Ratcliffe; J K Roberts
Journal:  J Exp Bot       Date:  2001-01       Impact factor: 6.992

4.  Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways.

Authors:  G E Hardingham; Y Fukunaga; H Bading
Journal:  Nat Neurosci       Date:  2002-05       Impact factor: 24.884

5.  Identification of the mitochondrial glutamate transporter. Bacterial expression, reconstitution, functional characterization, and tissue distribution of two human isoforms.

Authors:  Giuseppe Fiermonte; Luigi Palmieri; Simona Todisco; Gennaro Agrimi; Ferdinando Palmieri; John E Walker
Journal:  J Biol Chem       Date:  2002-03-15       Impact factor: 5.157

Review 6.  Epileptic encephalopathies in early infancy with suppression-burst.

Authors:  Shunsuke Ohtahara; Yasuko Yamatogi
Journal:  J Clin Neurophysiol       Date:  2003 Nov-Dec       Impact factor: 2.177

7.  Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal-regulated kinases (ERK) activity in cultured rat hippocampal neurons.

Authors:  Anton Ivanov; Christophe Pellegrino; Sylvain Rama; Iryna Dumalska; Yuriy Salyha; Yehezkel Ben-Ari; Igor Medina
Journal:  J Physiol       Date:  2006-05-01       Impact factor: 5.182

Review 8.  Biochemical and molecular investigations in respiratory chain deficiencies.

Authors:  P Rustin; D Chretien; T Bourgeron; B Gérard; A Rötig; J M Saudubray; A Munnich
Journal:  Clin Chim Acta       Date:  1994-07       Impact factor: 3.786

9.  Mutations in SLC25A22: hyperprolinaemia, vacuolated fibroblasts and presentation with developmental delay.

Authors:  Emma S Reid; Hywel Williams; Glenn Anderson; Malika Benatti; Kling Chong; Chela James; Louise Ocaka; Cheryl Hemingway; Daniel Little; Richard Brown; Alasdair Parker; Simon Holden; Emma Footitt; Shamima Rahman; Paul Gissen; Philippa B Mills; Peter T Clayton
Journal:  J Inherit Metab Dis       Date:  2017-03-02       Impact factor: 4.982

10.  SLC25A22 is a novel gene for migrating partial seizures in infancy.

Authors:  Annapurna Poduri; Erin L Heinzen; Vida Chitsazzadeh; Francesco Massimo Lasorsa; P Christina Elhosary; Christopher M LaCoursiere; Emilie Martin; Christopher J Yuskaitis; Robert Sean Hill; Kutay Deniz Atabay; Brenda Barry; Jennifer N Partlow; Fahad A Bashiri; Radwan M Zeidan; Salah A Elmalik; Mohammad M U Kabiraj; Sanjeev Kothare; Tommy Stödberg; Amy McTague; Manju A Kurian; Ingrid E Scheffer; A James Barkovich; Ferdinando Palmieri; Mustafa A Salih; Christopher A Walsh
Journal:  Ann Neurol       Date:  2013-12       Impact factor: 10.422

View more
  5 in total

Review 1.  Diseases Caused by Mutations in Mitochondrial Carrier Genes SLC25: A Review.

Authors:  Ferdinando Palmieri; Pasquale Scarcia; Magnus Monné
Journal:  Biomolecules       Date:  2020-04-23

Review 2.  Amino Acid Transport Defects in Human Inherited Metabolic Disorders.

Authors:  Raquel Yahyaoui; Javier Pérez-Frías
Journal:  Int J Mol Sci       Date:  2019-12-23       Impact factor: 5.923

3.  An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis.

Authors:  Yan-Jie Chen; Wei-Feng Hong; Meng-Ling Liu; Xi Guo; Yi-Yi Yu; Yue-Hong Cui; Tian-Shu Liu; Li Liang
Journal:  Cell Death Dis       Date:  2022-03-14       Impact factor: 9.685

Review 4.  Mitochondrial Carriers for Aspartate, Glutamate and Other Amino Acids: A Review.

Authors:  Magnus Monné; Angelo Vozza; Francesco Massimo Lasorsa; Vito Porcelli; Ferdinando Palmieri
Journal:  Int J Mol Sci       Date:  2019-09-10       Impact factor: 5.923

Review 5.  Mitochondrial Dysfunction: A Common Denominator in Neurodevelopmental Disorders?

Authors:  Xilma R Ortiz-González
Journal:  Dev Neurosci       Date:  2021-08-03       Impact factor: 3.421

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.